In this case, the magnitude of the anti-tumor effect appeared comparable to that recently described in mice vaccinated with vaccinia virus-based vectors expressing E7 fused with calreticulin, i.e., a protein strongly favoring Class I association of antigenic peptides [41]. Here, CALR is linked to neoplasm.